Medical devices company Aran Biomedical revealed on Monday the appointment of Todd Blair as vice president of its Sales and Business Development (US) to meet and manage the growing demand for its implantable biomaterial product solutions.
Effective 1 July 2020, Blair will support, identify and develop the company's new business opportunities into sustainable and long-term partnerships, lead internal teams on proposal and product solution development as well as oversee the sales and business development activities in the US marketplace with a primary focus on the Orthopaedic, General Surgery and Vascular fields.
Most recently, Blair has served as vice president of Corporate Strategy at Heraeus Medical Components.
The company said Todd brings to the new position more than 20 years of experience in sales and business development within the life sciences contract manufacturing industry, with a focus on Bio-Textiles, Nitinol devices and polymeric components.
Lupin's Ranluspec (ranibizumab) injection receives US FDA approval
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
Samsung Bioepis launches OPUVIZ across Europe for ophthalmic conditions
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Dexcom launches Dexcom Flex CGM system for Type 2 diabetes patients in Germany
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline
ZYUS Life Sciences receives second US pain management patent
Apotex receives Health Canada approval for a generic Ozempic equivalent